BioLife Solutions, Inc. (BLFS) vs Zymeworks Inc. (ZYME)

A side-by-side comparison of BioLife Solutions, Inc. and Zymeworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BLFS vs ZYME

growth of $100 · dividends reinvested · last 9y
BLFS +1765.2% (+38.4%/yr)ZYME +101.6% (+8.1%/yr)BLFS compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002019202120232025$1,865$202
BLFS ZYME

BLFS vs ZYME: by the numbers

  • •BLFS is the larger company ($1.89B vs $1.89B market cap).
  • •BLFS is profitable (49.06% net margin) while ZYME runs a net loss (-404.00%).
  • •ZYME grew revenue faster over the past five years (12.35% vs 6.78% CAGR).

Metrics side by side

Valuation

MetricBLFSZYME
P/E ratio37.72N/A
Forward P/E64.3524.70
P/S ratio18.3550.78
P/B ratio4.4923.46
EV / EBITDA170.26N/A

Profitability

MetricBLFSZYME
Gross margin64.48%100.00%
Operating margin-1.12%-87.33%
Net margin49.06%-404.00%
ROE12.01%-186.63%
ROIC1.72%-44.06%

Growth (annualized)

MetricBLFSZYME
Revenue CAGR (5Y)6.78%12.35%
Total return CAGR (5Y)-0.77%-1.37%

Frequently asked

Which has grown faster, BLFS or ZYME?
Over the past five years, ZYME grew revenue faster — BLFS at a 6.78% CAGR versus ZYME at 12.35%.
Is BLFS or ZYME more profitable?
BLFS runs the higher net margin — BLFS at 49.06% versus ZYME at -404.00%.
How have BLFS and ZYME total returns compared?
Over the past 5 years, BLFS delivered -0.77% and ZYME delivered -1.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.